Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000947871-26-000245·ORBIMED ADVISORS LLC
Schedule 13D ownership disclosure
Q32 BIO INC
COMMON STOCK · CUSIP: 746964105
Event date: 2026-02-18
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- ORBIMED ADVISORS LLCReported CIK 0001055951
Shares: 2,252,987.00 · Class: 15.4%
- ORBIMED CAPITAL GP VII LLCReported CIK 0001760648
Shares: 2,252,987.00 · Class: 15.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-26-000245
- Form type
- SCHEDULE 13D/A
- Filer
- ORBIMED ADVISORS LLC
- CIK
- CIK 1055951
- Filed
- Mar 12, 2026
- Reporting period
- Feb 18, 2026
- Description
- Schedule 13D beneficial ownership